A new survey with Social Prescribing Link Workers reflects the positive impact that their work is having – but highlights challenges around training and development, as well as gaps in community services.Â
Social Prescribing Link Workers were introduced into Primary Care Networks in 2019, as a shift towards more personalised care. Since then, more than 3,500 Link Workers have been recruited across England, and they have been highlighted as a core part of neighbourhood multidisciplinary teams.Â
 In March 2025, NASP surveyed more than 400 Link Workers across England*. The results show a workforce that is highly motivated, sees its work as meaningful, and reports strong job satisfaction. However, the survey also revealed variation in practice and satisfaction. Â
Looking ahead 
The findings offer valuable insights for NASP and our partners as we shape future priorities. Link Workers do an important and often difficult job, and a wide range of evidence shows the positive impact they are having both on individual patients and on the wider NHS. But the results of the survey show the need for:
-
Relevant community-based services and activities to be available in every area
-
Improved understanding and greater clarity about their role within the health system
-
Prioritising training, development and supervision.
In order to address these needs, NASP’s plans for the coming months include:
-
Continuing to advocate for new, shared funding approaches for activities and services that Link Workers can refer people to
-
Increasing understanding of social prescribing among health professionals, including through our Clinical Engagement Strategy and Social Prescribing Champions programme
-
Developing greater support for Link Workers, including through a Training and Development Roadmap, working closely with our Link Worker Advisory Group.
*Social Prescribing Link Workers (SPLWs) who hold a caseload and are based in England were invited to complete an online survey. 411 SPLWs responded between 5th Feb and 5th March. The survey was administered by the National Academy for Social Prescribing (NASP). Similar surveys were administered by NHS England in 2022 and 2023.